New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with $63.6 billion in annual revenue and an impressive 74% gross profit margin, has announced the U.S. Food and Drug Administration's ...

"It's a little overwhelming, but everyone's been so amazing and supportive and it makes me feel really great," junior Taylor LaRoche said, who was diagnosed with Hodgkin's Lymphoma last Christmas Eve ...

The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

The righthander can finally see the end of a long journey that started with a diagnosis of Stage 4 non-Hodgkin’s lymphoma in ...

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...